Franklin Biotechnology Discovery Fund Q4 2024 Commentary

featured-image

Morsa Images Performance Review During the fourth quarter of 2024 (4Q24), global stocks were pressured by investor concerns about economic growth, persistent inflation in some regions and the likelihood of further interest rate cuts in 2025. While Donald Trump’s presidential victory and the.